These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29936422)

  • 41. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.
    Kovatchev B; Cobelli C; Renard E; Anderson S; Breton M; Patek S; Clarke W; Bruttomesso D; Maran A; Costa S; Avogaro A; Dalla Man C; Facchinetti A; Magni L; De Nicolao G; Place J; Farret A
    J Diabetes Sci Technol; 2010 Nov; 4(6):1374-81. PubMed ID: 21129332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do-It-Yourself (DIY) Closed Loop Systems: Perspectives of an Endocrinologist.
    Hng TM
    J Diabetes Sci Technol; 2020 Nov; 14(6):1104-1106. PubMed ID: 31771354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes.
    Ng SM; Wright NP; Yardley D; Campbell F; Randell T; Trevelyan N; Ghatak A; Hindmarsh PC
    BMC Med; 2024 Apr; 22(1):175. PubMed ID: 38659016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Control to range for diabetes: functionality and modular architecture.
    Kovatchev B; Patek S; Dassau E; Doyle FJ; Magni L; De Nicolao G; Cobelli C;
    J Diabetes Sci Technol; 2009 Sep; 3(5):1058-65. PubMed ID: 20144419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the 'CLOSE IT' (Closed Loop Open SourcE In Type 1 diabetes) trial.
    Wilkinson T; Tomic D; Boyle E; Burren D; Elghattis Y; Jenkins A; Keesing C; Middleton S; Nanayakkara N; Williman J; de Bock M; Cohen ND
    BMJ Open; 2024 Feb; 14(2):e078171. PubMed ID: 38382954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose Control in Adults with Type 1 Diabetes Using a Medtronic Prototype Enhanced-Hybrid Closed-Loop System: A Feasibility Study.
    Lee MH; Vogrin S; Paldus B; Jones HM; Obeyesekere V; Sims C; Wyatt SA; Ward GM; McAuley SA; MacIsaac RJ; Krishnamurthy B; Sundararajan V; Jenkins AJ; O'Neal DN
    Diabetes Technol Ther; 2019 Sep; 21(9):499-506. PubMed ID: 31264889
    [No Abstract]   [Full Text] [Related]  

  • 48. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system.
    Ekhlaspour L; Forlenza GP; Chernavvsky D; Maahs DM; Wadwa RP; Deboer MD; Messer LH; Town M; Pinnata J; Kruse G; Kovatchev BP; Buckingham BA; Breton MD
    Pediatr Diabetes; 2019 Sep; 20(6):759-768. PubMed ID: 31099946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exposure to Closed Loop Barriers Using Virtual Reality.
    Lanning M; Shen J; Wasser D; Riddle S; Agustin B; Hood K; Naranjo D
    J Diabetes Sci Technol; 2020 Sep; 14(5):837-843. PubMed ID: 32019329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes.
    Nanayakkara N; Sharifi A; Burren D; Elghattis Y; Jayarathna DK; Cohen N
    J Diabetes Sci Technol; 2024 Jul; 18(4):889-896. PubMed ID: 36788715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do-It-Yourself (DIY) Systems in Diabetes: A Family and Provider Perspective.
    Duke MD; Fredlock AA
    J Diabetes Sci Technol; 2020 Sep; 14(5):917-921. PubMed ID: 32131623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
    Brown SA; Kovatchev BP; Raghinaru D; Lum JW; Buckingham BA; Kudva YC; Laffel LM; Levy CJ; Pinsker JE; Wadwa RP; Dassau E; Doyle FJ; Anderson SM; Church MM; Dadlani V; Ekhlaspour L; Forlenza GP; Isganaitis E; Lam DW; Kollman C; Beck RW;
    N Engl J Med; 2019 Oct; 381(18):1707-1717. PubMed ID: 31618560
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
    Klonoff DC; Kerr D
    J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
    [No Abstract]   [Full Text] [Related]  

  • 54. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.
    Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH;
    Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes.
    Stone JY; Haviland N; Bailey TS
    Ther Deliv; 2018 Feb; 9(2):77-87. PubMed ID: 29235423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perioperative Use of a Hybrid Closed Loop System in an Obese Patient With Type 1 Diabetes Undergoing Metabolic Surgery: Insights Into Changes in Insulin Delivery and Sensitivity.
    Rodriguez-Diaz E; Rizo I; Sullivan C; Steenkamp DW
    J Diabetes Sci Technol; 2018 Nov; 12(6):1239-1240. PubMed ID: 29957042
    [No Abstract]   [Full Text] [Related]  

  • 58. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
    Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
    J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Automated Insulin Delivery in Adults.
    Boughton CK; Hovorka R
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):167-178. PubMed ID: 31980116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes.
    Brown SA; Breton MD; Anderson SM; Kollar L; Keith-Hynes P; Levy CJ; Lam DW; Levister C; Baysal N; Kudva YC; Basu A; Dadlani V; Hinshaw L; McCrady-Spitzer S; Bruttomesso D; Visentin R; Galasso S; Del Favero S; Leal Y; Boscari F; Avogaro A; Cobelli C; Kovatchev BP
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3674-3682. PubMed ID: 28666360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.